Enanta Pharmaceuticals
ENTA
ENTA
81 hedge funds and large institutions have $339M invested in Enanta Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
23% more funds holding
Funds holding: 66 → 81 (+15)
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
Holders
81
Holding in Top 10
3
Calls
$412K
Puts
$12K
Top Buyers
| 1 | +$61.6M | |
| 2 | +$46.8M | |
| 3 | +$21.2M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$16.1M |
| 5 |
ICRM
Insight Capital Research & Management
Walnut Creek,
California
|
+$8.27M |
Top Sellers
| 1 | -$8.16M | |
| 2 | -$4.49M | |
| 3 | -$2.93M | |
| 4 |
Barclays
London,
United Kingdom
|
-$2.83M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.35M |